<SEC-DOCUMENT>0000930413-20-000369.txt : 20200214
<SEC-HEADER>0000930413-20-000369.hdr.sgml : 20200214
<ACCEPTANCE-DATETIME>20200214103116
ACCESSION NUMBER:		0000930413-20-000369
CONFORMED SUBMISSION TYPE:	SC 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20200214
DATE AS OF CHANGE:		20200214

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AETHLON MEDICAL INC
		CENTRAL INDEX KEY:			0000882291
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				133632859
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		SC 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-61769
		FILM NUMBER:		20615281

	BUSINESS ADDRESS:	
		STREET 1:		9635 GRANITE RIDGE DRIVE, SUITE 100
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92123
		BUSINESS PHONE:		858-459-7800

	MAIL ADDRESS:	
		STREET 1:		9635 GRANITE RIDGE DRIVE, SUITE 100
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92123

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BISHOP EQUITIES INC
		DATE OF NAME CHANGE:	19930602

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Iroquois Capital Management, LLC
		CENTRAL INDEX KEY:			0001481867
		IRS NUMBER:				010786483
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		SC 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		641 LEXINGTON AVENUE
		STREET 2:		26TH FLOOR
		CITY:			NEW YORK,
		STATE:			NY
		ZIP:			10022
		BUSINESS PHONE:		212.974.3070

	MAIL ADDRESS:	
		STREET 1:		641 LEXINGTON AVENUE
		STREET 2:		26TH FLOOR
		CITY:			NEW YORK,
		STATE:			NY
		ZIP:			10022
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G/A
<SEQUENCE>1
<FILENAME>c95268_sc13ga.htm
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-top: Black 1px solid">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE <BR>
COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; background-color: gray; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SCHEDULE 13G</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(Rule 13d-102)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>INFORMATION TO BE INCLUDED IN STATEMENTS
FILED PURSUANT<BR>
TO &sect; 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED<BR>
PURSUANT TO &sect; 240.13d-2.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(Amendment No.&nbsp;1)*</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: black 1px solid"><B>AETHLON MEDICAL,
INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Name of Issuer)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: black 1px solid"><B>Common Stock,
par value $0.001 per share</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Title of Class of Securities)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: black 1px solid"><B>00808Y307</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(CUSIP Number)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: black 1px solid"><B>December
31, 2019</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Date of Event Which Requires Filing of this
Statement)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Check the appropriate box to designate the rule pursuant to which
this Schedule is filed:</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR>
    <TD STYLE="width: 18pt">&nbsp;</TD>
    <TD STYLE="width: 25pt; text-align: left"><FONT STYLE="font-family: Wingdings">o</FONT></TD>
    <TD>Rule 13d-1(b)</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Wingdings">x</FONT></TD>
    <TD>Rule 13d-1(c)</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Wingdings">o</FONT></TD>
    <TD>Rule 13d-1(d)</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; background-color: gray; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">*The remainder of this cover page&nbsp;shall be filled out for a
reporting person&rsquo;s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment
containing information which would alter the disclosures provided in a prior cover page.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The information required in the remainder of this cover page&nbsp;shall
not be deemed to be &ldquo;filed&rdquo; for purposes of Section&nbsp;18 of the Securities Exchange Act of 1934 (&ldquo;Act&rdquo;)
or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; background-color: gray; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
</TABLE>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR>
    <TD COLSPAN="4" STYLE="border-bottom: black 1px solid; padding-bottom: 3pt; padding-left: 5pt">CUSIP No:&nbsp;00808Y307</TD></TR>
<TR>
    <TD STYLE="padding: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 3pt">(1)</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1px solid; padding: 3pt">Names of Reporting Persons<BR>
    Iroquois Capital Management L.L.C.</TD></TR>
<TR>
    <TD STYLE="padding: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 3pt">(2)</TD>
    <TD COLSPAN="2" STYLE="padding: 3pt">Check the Appropriate Box if a Member of a Group (See Instructions)</TD></TR>
<TR>
    <TD STYLE="padding: 3pt; width: 18pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 3pt; width: 36pt">&nbsp;</TD>
    <TD STYLE="padding: 3pt; width: 18pt">(a)</TD>
    <TD STYLE="border-bottom: black 1px solid; padding: 3pt"><FONT STYLE="font-family: Wingdings">o</FONT></TD></TR>
<TR>
    <TD STYLE="padding: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 3pt">&nbsp;</TD>
    <TD STYLE="padding: 3pt">(b)</TD>
    <TD STYLE="border-bottom: black 1px solid; padding: 3pt"><FONT STYLE="font-family: Wingdings">o</FONT></TD></TR>
<TR>
    <TD STYLE="padding: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 3pt">(3)</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; border-bottom: black 1px solid; padding: 3pt">SEC Use Only </TD></TR>
<TR>
    <TD STYLE="padding: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 3pt">(4)</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; border-bottom: black 1px solid; padding: 3pt">Citizenship or Place of Organization
    <BR>
    Delaware</TD></TR>
<TR>
    <TD COLSPAN="2" ROWSPAN="7" STYLE="padding: 3pt">Number of<BR>
    Shares<BR>
    Beneficially<BR>
    Owned by<BR>
    Each<BR>
    Reporting<BR>
    Person With</TD>
    <TD STYLE="vertical-align: top; padding: 3pt">(5)</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1px solid; padding: 3pt">Sole Voting Power <BR>
    0</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding: 3pt">(6)</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1px solid; padding: 3pt"><P STYLE="margin: 0">Shared Voting Power<BR>
        110,701 shares of Common Stock</P>
        <P STYLE="margin: 0">100,001 shares of Common Stock issuable upon exercise of Warrants (See Item 4)*</P>
        <P STYLE="margin: 0">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding: 3pt">(7)</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1px solid; padding: 3pt">Sole Dispositive Power <BR>
    0</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding: 3pt">(8)</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1px solid; padding: 3pt"><P STYLE="margin: 0">Shared Dispositive Power<BR>
        110,701 shares of Common Stock</P>
        <P STYLE="margin: 0">100,001 shares of Common Stock issuable upon exercise of Warrants (See Item 4)*</P>
        <P STYLE="margin: 0">&nbsp;</P></TD></TR>
<TR>
    <TD STYLE="padding: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 3pt"><P STYLE="margin: 0">&nbsp;</P>
        <P STYLE="margin: 0">(9)</P></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; border-bottom: black 1px solid; padding: 3pt"><P STYLE="margin: 0">&nbsp;</P>
        <P STYLE="margin: 0">Aggregate Amount Beneficially Owned by Each Reporting Person<BR>
        110,701 shares of Common Stock</P>
        <P STYLE="margin: 0">100,001 shares of Common Stock issuable upon exercise of Warrants (See Item 4)*</P></TD></TR>
<TR>
    <TD STYLE="padding: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 3pt">(10)</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; border-bottom: black 1px solid; padding: 3pt">Check Box if the Aggregate Amount
    in Row (9) Excludes Certain Shares (See Instructions)&nbsp;<FONT STYLE="font-family: Wingdings">o</FONT></TD></TR>
<TR>
    <TD STYLE="padding: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 3pt">(11)</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; border-bottom: black 1px solid; padding: 3pt">Percent of Class Represented
    by Amount in Row (9)<BR>
    6.3%</TD></TR>
<TR>
    <TD STYLE="padding: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 3pt">(12)</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; border-bottom: black 1px solid; padding: 3pt">Type of Reporting Person (See Instructions)<BR>
    OO</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">* As more fully described in Item 4, the Warrants are subject to
a 9.99% blocker, and the percentage set forth in row (11) gives effect to such blocker. However, as more fully described in Item
4, the securities reported in rows (6), (8) and (9) show the number of shares of Common Stock that would be issuable upon full
exercise of such reported securities and do not give effect to such blocker. Therefore, the actual number of shares of Common Stock
beneficially owned by such Reporting Person, after giving effect to such blocker, is less than the number of securities reported
in rows (6), (8) and (9).&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR>
    <TD COLSPAN="4" STYLE="border-bottom: black 1px solid; padding-bottom: 3pt; padding-left: 5pt">CUSIP No:&nbsp;00808Y307</TD></TR>
<TR>
    <TD STYLE="padding: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 3pt">(1)</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1px solid; padding: 3pt">Names of Reporting Persons<BR>
    Richard Abbe</TD></TR>
<TR>
    <TD STYLE="padding: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 3pt">(2)</TD>
    <TD COLSPAN="2" STYLE="padding: 3pt">Check the Appropriate Box if a Member of a Group (See Instructions)</TD></TR>
<TR>
    <TD STYLE="padding: 3pt; width: 18pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 3pt; width: 36pt">&nbsp;</TD>
    <TD STYLE="padding: 3pt; width: 18pt">(a)</TD>
    <TD STYLE="border-bottom: black 1px solid; padding: 3pt"><FONT STYLE="font-family: Wingdings">o</FONT></TD></TR>
<TR>
    <TD STYLE="padding: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 3pt">&nbsp;</TD>
    <TD STYLE="padding: 3pt">(b)</TD>
    <TD STYLE="border-bottom: black 1px solid; padding: 3pt"><FONT STYLE="font-family: Wingdings">o</FONT></TD></TR>
<TR>
    <TD STYLE="padding: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 3pt">(3)</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; border-bottom: black 1px solid; padding: 3pt">SEC Use Only </TD></TR>
<TR>
    <TD STYLE="padding: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 3pt">(4)</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; border-bottom: black 1px solid; padding: 3pt">Citizenship or Place of Organization
    <BR>
    United States of America</TD></TR>
<TR>
    <TD COLSPAN="2" ROWSPAN="7" STYLE="padding: 3pt">Number of<BR>
    Shares<BR>
    Beneficially<BR>
    Owned by<BR>
    Each<BR>
    Reporting<BR>
    Person With</TD>
    <TD STYLE="vertical-align: top; padding: 3pt">(5)</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1px solid; padding: 3pt"><P STYLE="margin: 0">Sole Voting Power<BR>
        66,466 shares of Common Stock</P>
        <P STYLE="margin: 0">66,667 shares of Common Stock issuable upon exercise of Warrants (See Item 4)*</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding: 3pt">(6)</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1px solid; padding: 3pt"><P STYLE="margin: 0">Shared Voting Power<BR>
        110,701 shares of Common Stock</P>
        <P STYLE="margin: 0">100,001 shares of Common Stock issuable upon exercise of Warrants (See Item 4)*</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding: 3pt">(7)</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1px solid; padding: 3pt"><P STYLE="margin: 0">Sole Dispositive Power<BR>
        66,466 shares of Common Stock</P>
        <P STYLE="margin: 0">66,667 shares of Common Stock issuable upon exercise of Warrants (See Item 4)*</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding: 3pt">(8)</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1px solid; padding: 3pt"><P STYLE="margin: 0">Shared Dispositive Power<BR>
        110,701 shares of Common Stock</P>
        <P STYLE="margin: 0">100,001 shares of Common Stock issuable upon exercise of Warrants (See Item 4)*</P></TD></TR>
<TR>
    <TD STYLE="padding: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 3pt"><P STYLE="margin: 0">&nbsp;</P>
        <P STYLE="margin: 0">(9)</P></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; border-bottom: black 1px solid; padding: 3pt"><P STYLE="margin: 0">&nbsp;</P>
        <P STYLE="margin: 0">Aggregate Amount Beneficially Owned by Each Reporting Person<BR>
        177,167 shares of Common Stock</P>
        <P STYLE="margin: 0">166,668 shares of Common Stock issuable upon exercise of Warrants (See Item 4)*</P></TD></TR>
<TR>
    <TD STYLE="padding: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 3pt">(10)</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; border-bottom: black 1px solid; padding: 3pt">Check Box if the Aggregate Amount
    in Row (9) Excludes Certain Shares (See Instructions)&nbsp;<FONT STYLE="font-family: Wingdings">o</FONT></TD></TR>
<TR>
    <TD STYLE="padding: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 3pt">(11)</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; border-bottom: black 1px solid; padding: 3pt">Percent of Class Represented
    by Amount in Row (9)<BR>
    9.99%</TD></TR>
<TR>
    <TD STYLE="padding: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 3pt">(12)</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; border-bottom: black 1px solid; padding: 3pt">Type of Reporting Person (See Instructions)<BR>
    IN; HC</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">* As more fully described in Item 4, the Warrants are subject to
a 9.99% blocker, and the percentage set forth in row (11) gives effect to such blocker. However, as more fully described in Item
4, the securities reported in rows (6), (8) and (9) show the number of shares of Common Stock that would be issuable upon full
exercise of such reported securities and do not give effect to such blocker. Therefore, the actual number of shares of Common Stock
beneficially owned by such Reporting Person, after giving effect to such blocker, is less than the number of securities reported
in rows (6), (8) and (9).&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR>
    <TD COLSPAN="4" STYLE="border-bottom: black 1px solid; padding-bottom: 3pt; padding-left: 5pt">CUSIP No:&nbsp;00808Y307</TD></TR>
<TR>
    <TD STYLE="padding: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 3pt">(1)</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1px solid; padding: 3pt">Names of Reporting Persons<BR>
    Kimberly Page</TD></TR>
<TR>
    <TD STYLE="padding: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 3pt">(2)</TD>
    <TD COLSPAN="2" STYLE="padding: 3pt">Check the Appropriate Box if a Member of a Group (See Instructions)</TD></TR>
<TR>
    <TD STYLE="padding: 3pt; width: 18pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 3pt; width: 36pt">&nbsp;</TD>
    <TD STYLE="padding: 3pt; width: 18pt">(a)</TD>
    <TD STYLE="border-bottom: black 1px solid; padding: 3pt"><FONT STYLE="font-family: Wingdings">o</FONT></TD></TR>
<TR>
    <TD STYLE="padding: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 3pt">&nbsp;</TD>
    <TD STYLE="padding: 3pt">(b)</TD>
    <TD STYLE="border-bottom: black 1px solid; padding: 3pt"><FONT STYLE="font-family: Wingdings">o</FONT></TD></TR>
<TR>
    <TD STYLE="padding: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 3pt">(3)</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; border-bottom: black 1px solid; padding: 3pt">SEC Use Only</TD></TR>
<TR>
    <TD STYLE="padding: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 3pt">(4)</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; border-bottom: black 1px solid; padding: 3pt">Citizenship or Place of Organization
    <BR>
    United States of America</TD></TR>
<TR>
    <TD COLSPAN="2" ROWSPAN="7" STYLE="padding: 3pt">Number of<BR>
    Shares<BR>
    Beneficially<BR>
    Owned by<BR>
    Each<BR>
    Reporting<BR>
    Person With</TD>
    <TD STYLE="vertical-align: top; padding: 3pt">(5)</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1px solid; padding: 3pt">Sole Voting Power <BR>
    0</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding: 3pt">(6)</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1px solid; padding: 3pt"><P STYLE="margin: 0">Shared Voting Power<BR>
                                         110,701 shares of Common Stock</P>
        <P STYLE="margin: 0">100,001 shares of Common Stock issuable upon exercise of Warrants (See Item 4)*</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding: 3pt">(7)</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1px solid; padding: 3pt">Sole Dispositive Power <BR>
    0</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding: 3pt">(8)</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1px solid; padding: 3pt"><P STYLE="margin: 0">Shared Dispositive Power<BR>
                                         110,701 shares of Common Stock</P>
        <P STYLE="margin: 0">100,001 shares of Common Stock issuable upon exercise of Warrants (See Item 4)*</P></TD></TR>
<TR>
    <TD COLSPAN="4" STYLE="padding-right: 3pt; padding-left: 3pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="padding: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 3pt">(9)</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; border-bottom: black 1px solid; padding: 3pt"><P STYLE="margin: 0">Aggregate
                                         Amount Beneficially Owned by Each Reporting Person<BR>
                                         110,701 shares of Common Stock</P>
        <P STYLE="margin: 0">100,001 shares of Common Stock issuable upon exercise of Warrants (See Item 4)*</P></TD></TR>
<TR>
    <TD STYLE="padding: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 3pt">(10)</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; border-bottom: black 1px solid; padding: 3pt">Check Box if the Aggregate Amount
    in Row (9) Excludes Certain Shares (See Instructions)&nbsp;<FONT STYLE="font-family: Wingdings">o</FONT></TD></TR>
<TR>
    <TD STYLE="padding: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 3pt">(11)</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; border-bottom: black 1px solid; padding: 3pt">Percent of Class Represented
    by Amount in Row (9)<BR>
    6.3%</TD></TR>
<TR>
    <TD STYLE="padding: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 3pt">(12)</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; border-bottom: black 1px solid; padding: 3pt">Type of Reporting Person (See Instructions)<BR>
    IN</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">* As more fully described in Item 4, the Warrants are subject to
a 9.99% blocker, and the percentage set forth in row (11) gives effect to such blocker. However, as more fully described in Item
4, the securities reported in rows (6), (8) and (9) show the number of shares of Common Stock that would be issuable upon full
exercise of such reported securities and do not give effect to such blocker. Therefore, the actual number of shares of Common Stock
beneficially owned by such Reporting Person, after giving effect to such blocker, is less than the number of securities reported
in rows (6), (8) and (9).&nbsp;</P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR>
    <TD STYLE="width: 100%; border-bottom: black 1px solid; padding-bottom: 3pt; padding-left: 5pt">CUSIP
    No:&nbsp;00808Y307</TD></TR>
</TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 3pt 0 0"><FONT STYLE="font-size: 10pt">This Amendment No. 1 (this &ldquo;Amendment&rdquo;)
amends the statement on Schedule 13G filed on December 18, 2019 (the &ldquo;Original Schedule 13G&rdquo;) with respect to the Common
Stock, $0.001 par value (the &ldquo;Common Stock&rdquo;) of</FONT> <FONT STYLE="font-size: 10pt">Aethlon Medical, Inc., a Nevada
corporation (the &ldquo;Company&rdquo;). Capitalized terms used herein and not otherwise defined in this Amendment have the meanings
set forth in the Original Schedule 13G. This Amendment amends and restates Item 4 in its entirety as set forth below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 10%; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Item 4.</B></FONT></TD>
    <TD STYLE="width: 90%; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Ownership</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Provide the following information regarding the aggregate number
and percentage of the class of securities of the issuer identified in Item 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 10pt">The information as of the date of
the event which requires filing of this statement required by Items 4(a) &#8211; (c) is set forth in Rows 5 &#8211; 11 of the cover
page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person. The percentage set
forth in Row 11 of the cover page for each Reporting Person is based on 3,237,522 shares of Common Stock issued and outstanding
as of December 17, 2019, as represented in the Company&rsquo;s press release dated December 17, 2019 and assumes the exercise of
the Company&rsquo;s reported warrants (the &ldquo;Reported Warrants&rdquo;)</FONT> <FONT STYLE="font-size: 10pt">subject to the
Blocker (as defined below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Pursuant to the terms of the Reported Warrants, the Reporting Persons
cannot exercise the Reported Warrants to the extent the Reporting Persons would beneficially own, after any such exercise, more
than 9.99% of the outstanding shares of Common Stock (the &ldquo;Blocker&rdquo;), and the percentage set forth in Row 11 of the cover
page for each Reporting Person gives effect to the Blocker. Consequently, as of the date of the event which requires the filing
of this statement, the Reporting Persons were not able to exercise all of the Reported Warrants due to the Blocker.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">As of the date of the event which requires filing of this statement,
Iroquois Master Fund Ltd. (&ldquo;Iroquois Master Fund&rdquo;) held 110,701 shares of Common Stock and Reported Warrants to purchase
100,001 shares of Common Stock (subject to the Blocker) and Iroquois Capital Investment Group LLC (&ldquo;ICIG&rdquo;) held 66,466
shares of Common Stock and Reported Warrants to purchase 66,667 shares of Common Stock (subject to the Blocker).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 10pt">Mr. Abbe shares authority and responsibility
for the investments made on behalf of Iroquois Master Fund with Ms. Kimberly Page, each of whom is a director of the Iroquois Master
Fund. As such, Mr. Abbe and Ms. Page may each be deemed to be the beneficial owner of all shares of Common Stock held by, and underlying
the Reported Warrants (subject to the Blocker) held by, Iroquois Master Fund. Iroquois Capital is the investment advisor for Iroquois
Master Fund and Mr. Abbe is the President of Iroquois Capital. Mr. Abbe has the sole authority and responsibility for the investments
made on behalf of ICIG. As such, Mr. Abbe may be deemed to be the beneficial owner of all shares of Common Stock held by,</FONT>
<FONT STYLE="font-size: 10pt">and underlying the Reported Warrants (subject to the Blocker) held by, Iroquois Master Fund and ICIG.
The foregoing should not be construed in and of itself as an admission by any Reporting Person as to beneficial ownership of shares
of Common Stock owned by another Reporting Person. Each of the Reporting Persons hereby disclaims any beneficial ownership of any
such shares of Common Stock except to the extent of their pecuniary interest therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 10%; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Item 10.</B></FONT></TD>
    <TD STYLE="width: 90%; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Certification</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">By signing below each of the undersigned certifies that, to the
best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with
the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection
with or as a participant in any transaction having that purpose or effect.</P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">After reasonable inquiry and to the best of my
knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Date: February 14, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 216pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom">IROQUOIS CAPITAL MANAGEMENT L.L.C.</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; width: 50%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 3%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 37%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 10%">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">By:</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1px solid">&nbsp;&nbsp;/s/ Richard Abbe </TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-left: 17pt">Richard Abbe, President</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; border-bottom: Black 1px solid">&nbsp;&nbsp;/s/ Richard Abbe </TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom">Richard Abbe</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; border-bottom: Black 1px solid">&nbsp;&nbsp;/s/ Kimberly Page </TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom">Kimberly Page&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>

    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
